RPRX (RPRX) Stock Price & Analysis
RPRX (RPRX) rose 0.13% to USD 63.96 as of September 8, 2026 at 03:30 UTC, according to Nexqual real-time market data.
RPRX last closed at USD 63.96; the session ranged USD 63.43–64.38 on volume of 3,402,567 shares. Market capitalization is —, with a 52-week range of USD 34.63–64.38 (NMS). Source: Nexqual, September 8, 2026 at 03:30 UTC.
Key Statistics (as of September 8, 2026 at 03:30 UTC)
| Price | USD 63.96 |
|---|---|
| Change | ▲ 0.13% (up) |
| Previous Close | USD 63.96 |
| Open | USD 63.96 |
| Day Range | USD 63.43 – 64.38 |
| 52-Week Range | USD 34.63 – 64.38 |
| Volume | 3,402,567 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (RPRX)
Nexqual's technical model rates RPRX "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 03:30 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 69.34 (neutral) |
| vs SMA50 | Above (USD 58.94) |
| MACD | 1.38 (positive) |
From RPRX's Latest SEC 10-K Filing (filed 2026-02-11)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GTM | ZoomInfo Technologies Inc. | USD 4.13 | ▲ 0.98% |
| NCNO | nCino, Inc. | USD 23.12 | ▲ 0.7% |
| CYTK | Cytokinetics, Incorporated | USD 72.72 | ▲ 1.1% |
| ALNY | Alnylam Pharmaceuticals, Inc. | USD 266.11 | ▼ 0.48% |
| GDRX | GoodRx Holdings, Inc. | USD 3.48 | ▲ 0.87% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 03:30 UTC. This page is informational and not investment advice.